These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30666131)

  • 1. Clinical significance of miR-195 in hepatocellular carcinoma and its biological function in tumor progression.
    Chen X; Wang A
    Onco Targets Ther; 2019; 12():527-534. PubMed ID: 30666131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma.
    Cao X; Yang Q; Yu Q
    Open Forum Infect Dis; 2020 Dec; 7(12):ofaa498. PubMed ID: 33364257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
    Cao C; Wang C
    Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
    Yang L; Xu Q; Xie H; Gu G; Jiang J
    Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells.
    Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J
    Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-424 Acts as a Novel Biomarker in the Diagnosis of Patients with Hepatocellular Carcinoma.
    Yang C; Du P; Lu W
    Cancer Biother Radiopharm; 2023 Dec; 38(10):670-673. PubMed ID: 34287021
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening.
    Li L; Guo Z; Wang J; Mao Y; Gao Q
    Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma.
    Yu F; Lu Z; Chen B; Dong P; Zheng J
    Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
    Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
    Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of MicroRNA-937 Predicts a Poor Prognosis and Promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion.
    Chen Z; Zhang Y
    Mol Biotechnol; 2022 Jan; 64(1):33-41. PubMed ID: 34519997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F; Ying H; He B; Pan Y; Sun H; Wang S
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma.
    Chen S; Chen H; Gao S; Qiu S; Zhou H; Yu M; Tu J
    Hepatol Res; 2017 Mar; 47(4):312-320. PubMed ID: 27152955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression level and diagnostic value of microRNA-22 in HCC patients.
    Zeng Z; Dong J; Li Y; Dong Z; Liu Z; Huang J; Wang Y; Zhen Y; Lu Y
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):683-686. PubMed ID: 32088997
    [No Abstract]   [Full Text] [Related]  

  • 16. Using circular RNA SMARCA5 as a potential novel biomarker for hepatocellular carcinoma.
    Li Z; Zhou Y; Yang G; He S; Qiu X; Zhang L; Deng Q; Zheng F
    Clin Chim Acta; 2019 May; 492():37-44. PubMed ID: 30716279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Diagnostic Value of miR-497 and miR-1246 in Hepatocellular Carcinoma.
    Chen S; Fu Z; Wen S; Yang X; Yu C; Zhou W; Lin Y; Lv Y
    Front Genet; 2021; 12():666306. PubMed ID: 34163524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma.
    Amr KS; Elmawgoud Atia HA; Elazeem Elbnhawy RA; Ezzat WM
    Genes Dis; 2017 Dec; 4(4):215-221. PubMed ID: 30258925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between down-expression of miR-431 and clinicopathological significance in HCC tissues.
    Pan L; Ren F; Rong M; Dang Y; Luo Y; Luo D; Chen G
    Clin Transl Oncol; 2015 Jul; 17(7):557-63. PubMed ID: 25775917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the microRNA-143/145 cluster is decreased in hepatitis B virus-associated hepatocellular carcinoma and may serve as a biomarker for tumorigenesis in patients with chronic hepatitis B.
    Zhao Q; Sun X; Liu C; Li T; Cui J; Qin C
    Oncol Lett; 2018 May; 15(5):6115-6122. PubMed ID: 29616093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.